Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity
Article in Biomaterials (July 2015)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL and CEACAM6
Article in Oncology Reports (April 2015)
CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas
Article in Virchows Archiv (November 2014)